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Objective: 
    Autoimmune hemolytic anaemia (AIHA) has a wide range of clinical 
presentation from mild to fulminant life threatening anaemia. Immunoglobulin 
class, subclass, titre, ability to activate complement, thermal amplitude and 
strength of direct antiglobulin test (DAT) have been implicated as factors 
affecting severity. This study was undertaken to analyze factors which influence 
the severity of AIHA in Indian population. 
 
Methodology-In this crosssectional study,all patients with evidence of 
haemolysis  and who were also positive for polyspecific DAT were 
included.DAT positive patient samples were further evaluated by monospecific 
DAT(column agglutination technique) to identify presence of IgG, IgM, IgA 
class and complement. If monospecific IgG was present, further subtyping was 
undertaken to identify the presence IgG1 and IgG3. Correlations were drawn 
between the severity of AIHA and Immunoglobulin class, strength of direct 
antiglobulintest (DAT,) IgG subtype and the titre of the latter.   
 
 
 
 
Results and Conclusion:  
Among 94 patients included in the analysis, the median age was 35.2(Range1-
77 years), with a male: female ratio of 1:1.9. Primary AIHA was identified in 
54.3% and secondary AIHA in 45.7%. Spread of autoantibodies identified 
included, 28.7% with solitary IgG followed by complement alone in 8.5% as 
opposed to 62.8% of patients who had a combination of autoantibodies. Severe 
haemolysis was greater in patients with primary AIHA (71.2%) as compared to 
patients with secondary AIHA(28.7%, p<0.001). 
Severe haemolysis was also seen in 89.1%, of patients who had a combination 
of autoantibodies as compared to 10.9% patients, with solitary IgG(p<0.001). 
IgG subtyping revealed the most common subtype to be IgG1(58.1%) followed 
by combination of IgG1 & IgG3 (11.6%).The remaining 30.2% were negative 
for IgG1or IgG3. Presence of IgG1 and IgG3 in combination, or IgG1alone 
showed statistically significant association with severity of haemolysis(p=0.04 
and 0.012respectively). Correlating strength of DAT revealed that severe 
haemolysis occurred in 80.8% patients with DAT strength of 4+ (p =0.006). 
This association was consistent even in the IgG subgroups where IgG1 and 
IgG3 were not detected However there was an association with complement 
fixation in this group. (p=0.04). 
 
Identifying patients with AIHA at risk of severe haemolysis is critical for 
prognostication, appropriate intervention and follow up planning. This 
association in our study of DAT strength, IgG1 and IgG3 positivity, and 
complement fixation on severity of haemolysis suggest that an algorithm of 
following up DAT positivity, in patients with AIHA, with a monospecific DAT 
and IgG subtype analysis will allow for identification of this critical subgroup of 
patients in whom more intense clinical intervention and close follow up might 
be indicated. 
 
